Literature DB >> 27686230

Correlation of blood biomarkers with age informs pathomechanisms in succinic semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism.

E E Jansen1, K R Vogel2, G S Salomons2, P L Pearl3, J-B Roullet2, K M Gibson4.   

Abstract

We hypothesized that blood levels of γ-aminobutyric acid (GABA) and γ-hydroxybutyric acid (GHB), biomarkers of succinic semialdehyde dehydrogenase deficiency (SSADHD), would correlate with age. GABA and GHB were quantified in plasma and red blood cells (RBCs) from 18 patients (age range 5-41 years; median 8). Both metabolites negatively correlated with age (P < 0.05). Plasma and RBC GHB declined with age, reaching a nadir and approximate steady state by 10 years. Declining plasma GABA achieved this approximate steady state at 30-40 years of age. These biomarker relationships may reflect further GABA- and GHB-ergic neurotransmission imbalances that correlate with the onset of adolescent/adulthood neuropsychiatric morbidity and epilepsy in SSADHD.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27686230      PMCID: PMC5115636          DOI: 10.1007/s10545-016-9980-7

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  26 in total

1.  GABAB-ergic motor cortex dysfunction in SSADH deficiency.

Authors:  Janine Reis; Leonardo G Cohen; Phillip L Pearl; Brita Fritsch; Nikolai H Jung; Irene Dustin; William H Theodore
Journal:  Neurology       Date:  2012-06-20       Impact factor: 9.910

2.  Vigabatrin therapy in six patients with succinic semialdehyde dehydrogenase deficiency.

Authors:  K M Gibson; C Jakobs; H Ogier; L Hagenfeldt; K E Eeg-Olofsson; O Eeg-Olofsson; F Aksu; H P Weber; E Rossier; B Vollmer
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

3.  Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency.

Authors:  P L Pearl; K M Gibson; Z Quezado; I Dustin; J Taylor; S Trzcinski; J Schreiber; K Forester; P Reeves-Tyer; C Liew; S Shamim; P Herscovitch; R Carson; J Butman; C Jakobs; W Theodore
Journal:  Neurology       Date:  2009-08-11       Impact factor: 9.910

4.  Quantitation of gamma-hydroxybutyric acid in dried blood spots: feasibility assessment for newborn screening of succinic semialdehyde dehydrogenase (SSADH) deficiency.

Authors:  Sabrina Forni; Phillip L Pearl; K Michael Gibson; Yuezhou Yu; Lawrence Sweetman
Journal:  Mol Genet Metab       Date:  2013-05-10       Impact factor: 4.797

5.  Neuropathology in succinic semialdehyde dehydrogenase deficiency.

Authors:  Ina Knerr; K Michael Gibson; Geoffrey Murdoch; Gajja S Salomons; Cornelis Jakobs; Susan Combs; Phillip L Pearl
Journal:  Pediatr Neurol       Date:  2010-04       Impact factor: 3.372

6.  Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria).

Authors:  K Michael Gibson; Maneesh Gupta; Phillip L Pearl; Mendel Tuchman; L Gilbert Vezina; O Carter Snead; Leo M E Smit; Cornelis Jakobs
Journal:  Biol Psychiatry       Date:  2003-10-01       Impact factor: 13.382

Review 7.  Mechanisms for the Specific Properties of γ-Hydroxybutyrate in Brain.

Authors:  Michel Maitre; Christian Klein; Ayikoe G Mensah-Nyagan
Journal:  Med Res Rev       Date:  2016-01-06       Impact factor: 12.944

8.  mTOR inhibitors rescue premature lethality and attenuate dysregulation of GABAergic/glutamatergic transcription in murine succinate semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism.

Authors:  Kara R Vogel; Garrett R Ainslie; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2016-08-12       Impact factor: 4.982

Review 9.  Succinic semialdehyde dehydrogenase deficiency (SSADHD): Pathophysiological complexity and multifactorial trait associations in a rare monogenic disorder of GABA metabolism.

Authors:  P Malaspina; J-B Roullet; P L Pearl; G R Ainslie; K R Vogel; K M Gibson
Journal:  Neurochem Int       Date:  2016-06-14       Impact factor: 3.921

10.  Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development.

Authors:  Erwin E W Jansen; Eduard Struys; Cornelis Jakobs; Elizabeth Hager; O Carter Snead; K Michael Gibson
Journal:  BMC Dev Biol       Date:  2008-11-28       Impact factor: 1.978

View more
  9 in total

1.  Gamma-Hydroxybutyrate (GHB) Content in Hair Samples Correlates Negatively with Age in Succinic Semialdehyde Dehydrogenase Deficiency.

Authors:  S S Johansen; X Wang; D Sejer Pedersen; P L Pearl; J-B Roullet; G R Ainslie; K R Vogel; K M Gibson
Journal:  JIMD Rep       Date:  2017-02-18

2.  Gamma-Hydroxybutyrate content in dried bloodspots facilitates newborn detection of succinic semialdehyde dehydrogenase deficiency.

Authors:  Madalyn Brown; Paula Ashcraft; Erland Arning; Teodoro Bottiglieri; Jean-Baptiste Roullet; K Michael Gibson
Journal:  Mol Genet Metab       Date:  2019-07-18       Impact factor: 4.797

3.  Post-mortem tissue analyses in a patient with succinic semialdehyde dehydrogenase deficiency (SSADHD). I. Metabolomic outcomes.

Authors:  Trevor Kirby; Dana C Walters; Madalyn Brown; Erwin Jansen; Gajja S Salomons; Coleman Turgeon; Piero Rinaldo; Erland Arning; Paula Ashcraft; Teodoro Bottiglieri; Jean-Baptiste Roullet; K Michael Gibson
Journal:  Metab Brain Dis       Date:  2020-03-14       Impact factor: 3.584

4.  Enzyme Replacement Therapy for Succinic Semialdehyde Dehydrogenase Deficiency: Relevance in γ-Aminobutyric Acid Plasticity.

Authors:  Henry Hing Cheong Lee; Phillip L Pearl; Alexander Rotenberg
Journal:  J Child Neurol       Date:  2021-02-24       Impact factor: 1.987

5.  Postmortem Analyses in a Patient With Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD): II. Histological, Lipid, and Gene Expression Outcomes in Regional Brain Tissue.

Authors:  Dana C Walters; Regan Lawrence; Trevor Kirby; Jared T Ahrendsen; Matthew P Anderson; Jean-Baptiste Roullet; Eric J Murphy; K Michael Gibson
Journal:  J Child Neurol       Date:  2021-02-09       Impact factor: 1.987

6.  Magnetic Resonance Imaging (MRI) and Spectroscopy in Succinic Semialdehyde Dehydrogenase Deficiency.

Authors:  Onur Afacan; Edward Yang; Alexander P Lin; Eduardo Coello; Melissa L DiBacco; Phillip L Pearl; Simon K Warfield; Ssadh Deficiency Investigators Consortium
Journal:  J Child Neurol       Date:  2021-02-09       Impact factor: 1.987

Review 7.  Understanding the Molecular Mechanisms of Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD): Towards the Development of SSADH-Targeted Medicine.

Authors:  Henry H C Lee; Gabrielle E McGinty; Phillip L Pearl; Alexander Rotenberg
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

8.  In vitro modeling of experimental succinic semialdehyde dehydrogenase deficiency (SSADHD) using brain-derived neural stem cells.

Authors:  Kara R Vogel; Garrett R Ainslie; Erwin E Jansen; Gajja S Salomons; Jean-Baptiste Roullet; K Michael Gibson
Journal:  PLoS One       Date:  2017-10-20       Impact factor: 3.240

9.  Novel biomarkers and age-related metabolite correlations in plasma and dried blood spots from patients with succinic semialdehyde dehydrogenase deficiency.

Authors:  Trevor Kirby; Dana C Walters; Xutong Shi; Coleman Turgeon; Piero Rinaldo; Erland Arning; Paula Ashcraft; Teodoro Bottiglieri; Melissa DiBacco; Phillip L Pearl; Jean-Baptiste Roullet; K Michael Gibson
Journal:  Orphanet J Rare Dis       Date:  2020-09-23       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.